Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma.

Genolla J, Rodriguez T, Minguez P, Lopez-Almaraz R, Llorens V, Echebarria A.

Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1567-1575. doi: 10.1007/s00259-019-04291-x. Epub 2019 Mar 5.

PMID:
30838430
2.

Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.

Gabilondo I, Llorens V, Rodriguez T, Fernández M, Concha TP, Acera M, Tijero B, Murueta-Goyena A, Del Pino R, Cortés J, Gómez-Esteban JC.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):376-384. doi: 10.1007/s00259-018-4183-0. Epub 2018 Oct 15.

PMID:
30324423
3.

New imaging techniques in retinal vasculitis.

Mesquida M, Llorens V, Adán A.

Med Clin (Barc). 2017 Sep 20;149(6):261-266. doi: 10.1016/j.medcli.2017.05.009. Epub 2017 Jul 5. Review. English, Spanish.

PMID:
28687121
4.

Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma.

Andrés-Guerrero V, Perucho-González L, García-Feijoo J, Morales-Fernández L, Saenz-Francés F, Herrero-Vanrell R, Júlvez LP, Llorens VP, Martínez-de-la-Casa JM, Konstas AG.

Adv Ther. 2017 Feb;34(2):378-395. doi: 10.1007/s12325-016-0461-z. Epub 2016 Dec 20. Review.

5.

Evaluation of Objective Vitritis Grading Method Using Optical Coherence Tomography: Influence of Phakic Status and Previous Vitrectomy.

Zarranz-Ventura J, Keane PA, Sim DA, Llorens V, Tufail A, Sadda SR, Dick AD, Lee RW, Pavesio C, Denniston AK, Adan A; EQUATOR Study Group.

Am J Ophthalmol. 2016 Jan;161:172-80.e1-4. doi: 10.1016/j.ajo.2015.10.009. Epub 2015 Oct 23.

6.

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations.

Tijero B, Gabilondo I, Lezcano E, Teran-Villagrá N, Llorens V, Ruiz-Martinez J, Marti-Masso JF, Carmona M, Luquin MR, Berganzo K, Fernandez I, Fernandez M, Zarranz JJ, Gómez-Esteban JC.

Parkinsonism Relat Disord. 2015 Jul;21(7):717-22. doi: 10.1016/j.parkreldis.2015.04.012. Epub 2015 Apr 23.

PMID:
25960264
7.

Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension.

Pérez T, Tijero B, Gabilondo I, Luna A, Llorens V, Berganzo K, Acera M, Gonzalez A, Sanchez-Ferro A, Lezcano E, Zarranz JJ, Gómez-Esteban JC.

J Hum Hypertens. 2015 Oct;29(10):604-9. doi: 10.1038/jhh.2014.131. Epub 2015 Jan 29.

PMID:
25631216
8.

[Retinal vasculopathy in systemic lupus erythematosus: a case of lupus vasculitis and a case of non-vasculitis venous occlusion].

Figueras-Roca M, Rey A, Mesquida M, Pelegrín L, Llorens V, Fontenla JR, Adán A.

Arch Soc Esp Oftalmol. 2014 Feb;89(2):66-9. doi: 10.1016/j.oftal.2012.06.030. Epub 2012 Oct 8. Spanish.

PMID:
24269411
9.

Arterial pseudoaneurysm as a false positive for infection in bone scintigraphy and with labelled leukocytes in a patient with total hip prosthesis.

Guayambuco S, Llorens V, Genollá J, Rodríguez T, Rodeño E, Fernández I, Delgado A, Fombellida J.

Rev Esp Med Nucl Imagen Mol. 2013 Sep-Oct;32(5):334-5. doi: 10.1016/j.remn.2012.12.002. Epub 2013 Jul 18. English, Spanish. No abstract available.

10.

Autonomic dysfunction in parkinsonian LRRK2 mutation carriers.

Tijero B, Gómez Esteban JC, Somme J, Llorens V, Lezcano E, Martinez A, Rodríguez T, Berganzo K, Zarranz JJ.

Parkinsonism Relat Disord. 2013 Oct;19(10):906-9. doi: 10.1016/j.parkreldis.2013.05.008. Epub 2013 Jun 10.

PMID:
23764467
11.

Nocturnal hypertension and dysautonomia in patients with Parkinson's disease: are they related?

Berganzo K, Díez-Arrola B, Tijero B, Somme J, Lezcano E, Llorens V, Ugarriza I, Ciordia R, Gómez-Esteban JC, Zarranz JJ.

J Neurol. 2013 Jul;260(7):1752-6. doi: 10.1007/s00415-013-6859-5. Epub 2013 Feb 15.

PMID:
23412356
12.

Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the α synuclein gene.

Tijero B, Gómez-Esteban JC, Lezcano E, Fernández-González C, Somme J, Llorens V, Martínez A, Ruiz-Martínez J, Foncea N, Escalza I, Berganzo K, Aniel-Quiroga MA, Ruiz V, Terán N, Kaufmann H, Zarranz JJ.

Parkinsonism Relat Disord. 2013 Jan;19(1):95-100. doi: 10.1016/j.parkreldis.2012.08.001. Epub 2012 Sep 19.

PMID:
23000061
13.

[Teratoma in a case of encephalitis due to antibodies against the NMDA receptor].

Gómez-Esteban JC, Agundez M, Ciordia R, Zarranz JJ, Llorens V.

Rev Neurol. 2011 Nov 1;53(9):574. Spanish. No abstract available.

14.

SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.

Berganzo K, Tijero B, Somme JH, Llorens V, Sánchez-Manso JC, Low D, Iodice V, Vichayanrat E, Mathias CJ, Lezcano E, Zarranz JJ, Gómez-Esteban JC.

Parkinsonism Relat Disord. 2012 Jan;18(1):45-8. doi: 10.1016/j.parkreldis.2011.08.018. Epub 2011 Sep 9.

PMID:
21908227
15.

Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the alpha-synuclein gene (SNCA).

Tijero B, Gomez-Esteban JC, Llorens V, Lezcano E, Gonzalez-Fernández MC, de Pancorbo MM, Ruiz-Martinez J, Cembellin JC, Zarranz JJ.

Clin Auton Res. 2010 Aug;20(4):267-9. doi: 10.1007/s10286-010-0068-4. Epub 2010 May 5.

PMID:
20443127
16.

Abnormal multifocal cerebral blood flow on Tc-99m HMPAO SPECT in a patient with anti-NMDA-receptor encephalitis.

Llorens V, Gabilondo I, Gómez-Esteban JC, Agundez M, Mendibe M, Bergara JC, Ciordia R, Saiz A, Zarranz JJ.

J Neurol. 2010 Sep;257(9):1568-9. doi: 10.1007/s00415-010-5546-z. Epub 2010 Mar 30. No abstract available.

PMID:
20352245
17.

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.

Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atarés B, Llorens V, Gomez Tortosa E, del Ser T, Muñoz DG, de Yebenes JG.

Ann Neurol. 2004 Feb;55(2):164-73.

PMID:
14755719
18.

Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.

Takimoto CH, Glover K, Huang X, Hayes SA, Gallot L, Quinn M, Jovanovic BD, Shapiro A, Hernandez L, Goetz A, Llorens V, Lieberman R, Crowell JA, Poisson BA, Bergan RC.

Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1213-21.

19.

A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients.

Thomas RR, Dahut W, Harold N, Grem JL, Monahan BP, Liang M, Band RA, Cottrell J, Llorens V, Smith JA, Corse W, Arbuck SG, Wright J, Chen AP, Shapiro JD, Hamilton JM, Allegra CJ, Takimoto CH.

Cancer Chemother Pharmacol. 2001 Sep;48(3):215-22.

PMID:
11592343
20.

[Experimental comparative study of the anti-inflammatory effectiveness of pranoprofen].

Andrés RC, Moreno OR, Marín Del Tiempo D, Aragués AR, Llorens VP, Gonzalvo F, López FH.

Arch Soc Esp Oftalmol. 2000;75(5):327-32. Spanish.

PMID:
11151170
21.

[Antiinflammatory capacity of topical ketorolac in experimental model of ocular inflammation].

Moreno OR, Andrés RC, Júlvez LP, Llorens VP, Marín Del Tiempo D, Novella EF, Torrón C, Honrubia FM.

Arch Soc Esp Oftalmol. 2000;75(5):333-8. Spanish.

PMID:
11151171
22.

Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer.

Breathnach OS, Georgiadis MS, Schuler BS, Pizzella P, Llorens V, Kasturi V, Steinberg SM, O'Neil K, Takimoto CH, Johnson BE.

Clin Cancer Res. 2000 Jul;6(7):2670-6.

23.

Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients.

Takimoto CH, Morrison G, Harold N, Quinn M, Monahan BP, Band RA, Cottrell J, Guemei A, Llorens V, Hehman H, Ismail AS, Flemming D, Gosky DM, Hirota H, Berger SJ, Berger NA, Chen AP, Shapiro JD, Arbuck SG, Wright J, Hamilton JM, Allegra CJ, Grem JL.

J Clin Oncol. 2000 Feb;18(3):659-67.

PMID:
10653882
24.

Diaschisis and neuropsychological performance after cerebellar stroke.

Gómez Beldarrain M, García-Moncó JC, Quintana JM, Llorens V, Rodeño E.

Eur Neurol. 1997;37(2):82-9.

PMID:
9058062
25.

Radionuclide visualization of a thoracic renal ectopia.

Serena A, Duque JJ, Cotero A, Lloréns V, Fombellida JC.

Clin Nucl Med. 1994 Nov;19(11):1021-2. No abstract available.

PMID:
7842579
26.

[The gammagraphic diagnosis of acute pulmonary thromboembolism].

Capelastegui A, Oribe M, Esteban C, Llorens V, Miguélez JL, Marco A.

Arch Bronconeumol. 1994 Oct;30(8):381-4. Spanish.

PMID:
7987544
27.

Abdominal activity in cerebrospinal fluid cisternography.

Verdú J, Rodriguez ML, Rodeño E, Zapirain JM, Llorens V, Fombellida JC.

Clin Nucl Med. 1994 Mar;19(3):245-6. No abstract available.

PMID:
8033481
28.

Neuropsychological differences but comparable regional cerebral blood changes in asymptomatic HIV-1-positive and -negative drug addicts.

Beldarrain MG, García-Moncó JC, Llorens V, Cortés J, Mayo J.

Eur Neurol. 1994;34(4):193-8.

PMID:
8082677
29.

[Determination of steroid hormone receptors in supernatants obtained by low velocity centrifugation. Preliminary study].

Genollà J, Serena A, Llorens V, Fombellida JC.

Med Clin (Barc). 1991 Nov 9;97(16):636-7. Spanish. No abstract available.

PMID:
1766290
30.

Gallium-67 citrate scintigraphy in Salmonella infected thrombus of a left ventricular aneurysm.

de la Fuente C, Llorens V, Banzo I, Carril JM.

J Nucl Med. 1989 Jul;30(7):1277-8. No abstract available.

31.

[Contribution of gammography with gallium-67 to the study of pulmonary sarcoidosis].

Banzo JI, de la Fuente C, Llorens V, Arnal C, Carril JM.

Med Clin (Barc). 1988 Feb 13;90(6):233-6. Spanish. No abstract available.

PMID:
3352368
32.

[Evaluation of iron deposits in blood donors by determining serum ferritin using radioimmunoassay].

Cordovilla JJ, de la Fuente C, Llorens V, Pastor JM, Hermosa V, Carril JM.

Rev Clin Esp. 1987 Jun;181(2):75-8. Spanish. No abstract available.

PMID:
3628903
33.

[Anuria without shock in acute pancreatitis].

Llorens V, Rey C, Pedreira JD, Foz M, Gómez Pérez J.

Rev Esp Enferm Apar Dig. 1978 Feb 15;52(4):493-8. Spanish. No abstract available.

PMID:
653081
34.

[Osteomyelosclerosis of more than 20 years of evolution].

Vilaseca J, Garnacho A, Rona V, Bartolomé J, Rey C, Llorens V, Bacardi R.

Rev Clin Esp. 1977 Aug 15-31;146(3-4):185-90. Spanish. No abstract available.

PMID:
918324
35.

[Relation between ischemic cardiopathy and cholelithiasis. Autopsy study].

Gómez Saez JM, Sendra SJ, Llorens V, Moragas A.

Rev Clin Esp. 1977 Feb 15;144(3):181-5. Spanish. No abstract available.

PMID:
841144
36.

[Hypogammaglobulinemia and malabsorption syndrome. Apropos of 8 cases].

Frison JC, Llorens V, Richart C, Morell F, Rosales S, Caralps A, Bacardi R.

Rev Esp Enferm Apar Dig. 1975 Oct;46(4):393-402. Spanish. No abstract available.

PMID:
1208951
37.

[Intestinal invagination caused by lymphoma during childhood. Apropos of a case in an 8-year-old boy].

Vilaseca J, Garnacho A, Llorens V, Blanes R, Bonafonte M, Mari L.

Rev Esp Enferm Apar Dig. 1974 Nov 15;44(6):605-12. Spanish. No abstract available.

PMID:
4438789
38.

[Heavy chain disease (Seligman's disease)].

Guardia J, Moragas A, Pedreira JD, Ferragut A, Gómez-Pérez J, Martínez-Vázquez JM, Llorens V.

Rev Clin Esp. 1972 Nov 30;127(4):923-6. Spanish. No abstract available.

PMID:
4651708

Supplemental Content

Loading ...
Support Center